000 | 01937nam a22003615i 4500 | ||
---|---|---|---|
001 | 21051682 | ||
003 | OSt | ||
005 | 20220328095840.0 | ||
008 | 190702s2019 mau 000 0 eng | ||
010 | _a 2019945014 | ||
020 |
_a9780128135396 _q(paperback) |
||
020 |
_z9780128135402 _q(ebook) |
||
035 | _aGSU027394 | ||
040 |
_aLCC _benglish _erda _cGSU _dGSU |
||
042 | _apcc | ||
050 | _aR853JOR | ||
100 | _aJorgensen Trost Jan | ||
245 | 0 | 0 |
_aCompanion and complementary diagnostics : _bfrom biomarker discovery to clinical implementation / _cJan Trøst Jørgensen. |
263 | _a1907 | ||
264 | 1 |
_aCambridge : _bElsevier, _c2019. |
|
300 | _axvii,489pages; | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aincludes index | ||
505 | _aImmunohistochemistry,in situ hybridization,an introduction to campanion and complementary diagnostics | ||
520 |
_a"Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation provides readers with in-depth insights into the individual steps in the development of companion diagnostic assays, from the early biomarker discovery phase straight through to final regulatory approval. Further, the clinical implementation of companion diagnostic testing in the clinic is also discussed. As the development of predictive or selective biomarker assays linked to specific drugs is substantially increasing, this book offers comprehensive information on this quickly-evolving area of biomedicine. It is an essential resource for those in academic institutions, hospitals and pharma, and biotech and diagnostic commercial companies"-- _cProvided by publisher. |
||
650 | _aCompanion and Complementary Diagnostics | ||
700 | 1 |
_aJørgensen, Jan Trøst, _eeditor. |
|
906 |
_a0 _bibc _corignew _d2 _eepcn _f20 _gy-gencatlg |
||
942 |
_2lcc _cBK _n0 |
||
999 |
_c366 _d366 |